π§© The classic clue is a boy with delayed puberty and anosmia (loss of smell).
This reflects the embryological failure of GnRH neurons to migrate alongside olfactory neurons.
π§ About Kallmann's Syndrome
- Inherited form of secondary hypogonadism (hypogonadotropic hypogonadism).
- Caused by congenital failure of olfactory lobe development and GnRH deficiency.
- Often presents in adolescence with absent puberty and impaired sense of smell.
𧬠Genetics
- Modes of inheritance: X-linked recessive (XLR), autosomal dominant (AD), or autosomal recessive (AR).
- Mutations in KAL1 (anosmin-1) or FGFR1 (KAL2) genes implicated.
- ~50% of cases have identifiable genetic mutations; others are sporadic.
βοΈ Aetiology & Pathophysiology
- Failure of GnRH-secreting neurons to migrate to the hypothalamus during embryogenesis.
- Lack of GnRH β β LH & FSH β reduced testosterone/oestradiol β delayed or absent puberty.
- Olfactory bulb aplasia/atrophy explains anosmia.
π€ Clinical Features
- π« Anosmia or hyposmia (loss/reduced smell).
- π§β𦱠Delayed puberty or absent secondary sexual characteristics.
- π¨ Cryptorchidism, small testes, micropenis (in males).
- Associated anomalies: cleft lip/palate, colour blindness, renal agenesis, hearing loss, mirror movements (synkinesia).
π¬ Investigations
- π§ͺ Hormones: β Testosterone, β/inappropriately normal LH & FSH.
- π§ββοΈ Differentiate from primary hypogonadism (β LH/FSH, e.g. in Klinefelterβs).
- π§² MRI brain: absent olfactory bulbs, pituitary assessment.
- 𧬠Genetic testing (FISH / sequencing) for confirmation.
π Management
- π Hormone replacement therapy: Testosterone (males) or oestrogen/progesterone (females).
- π§ͺ Pulsatile GnRH or gonadotropin therapy (hCG/FSH) to induce fertility if desired.
- π¨βπ©βπ§ Genetic counselling for affected families.
- π€ Supportive care: psychological support, fertility planning, monitoring bone health.